The role of the endocannabinoid system in FXS, its dysregulation due to the absence of Fragile X Messenger Ribonucleoprotein (FMRP), and the potential role of CBD has been previously described [13, 30]. The gene discussed is FMR1; the disease is fragile X syndrome.